3650 results for «382»
3650 results
Transcatheter mitral valve repair for degenerative mitral regurgitation - LIVE Case
23 May 2019 – From EuroPCR 2019
Consult this live transmission from EuroPCR 2019 to discover the case of a 87 years-old female, who has been referred for degenerative mitral regurgitation. Watch it now to find out about the treatment's choice!
LIVE demonstration from Rigshospitalet, University of Copenhagen - Copenhagen, Denmark
Complex aortoiliac bifurcation treatment - LIVE Case
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to select the best vascular access option (single versus multiple) and how to drive your device choice for patient-/lesion-individualised treatment.
LIVE demonstration from Clinique Pasteur - Toulouse, France
EuroPCR 2019 Closing Ceremony
24 May 2019 – From EuroPCR 2019
Consult this session to discover EuroPCR 2019 Closing Ceremony, where Andreas Baumbach - president of the EAPCI - highlights the key moments of the course, and what makes it unique.
Stay put: a surprise awaits you at the end!
That year, EuroPCR gathered 11,206 active participants; warm thanks to all...
TAVI in horizontal aorta
22 May 2019 – From EuroPCR 2019
Consult this session to discover a LIVE demonstration from St. Johannes Hospital - Dortmund, Germany, regarding TAVI in horizontal aorta, transmitted live during EuroPCR 2019. The patient here is a 78 years-old male presenting with progressive dyspnea (NYHA III) and angina pectoris (CCS-III), whose echography shows...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.
Author
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines
29 Aug 2021
There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...
Author
Evidence base: current data on TAVI durability and long-term outcomes
18 Jun 2026
This article reviews the current evidence on TAVI durability, focusing on long-term outcomes, device-specific considerations, and the implications for lifetime management strategies.
Author
Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.
Author
